Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011;66(3):521-2.
doi: 10.1590/s1807-59322011000300029.

Thiocolchicoside-induced liver injury

Cumali Efe  1 , Tugrul Purnak, Ersan Ozaslan, Aysel Milanlioglu
Affiliations
Case Reports

Thiocolchicoside-induced liver injury

Cumali Efe et al. Clinics (Sao Paulo). 2011.
No abstract available

PubMed Disclaimer

References

    1. Review article: drug-induced liver injury in clinical practice. Björnsson E. Aliment Pharmacol Ther. 2010;32:3–13. - PubMed
    1. Janbroers JM. Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with anti-inflammatory and analgesic actions. Acta Ther. 1987;13:221–7.
    1. De Riu PL, Rosati G, Sotgiu S, Sechi G. Epileptic seizures after treatment with thiocolchicoside. Epilepsia. 2001;42:1084–6. 10.1046/j.1528-1157.2001.0420081084.x - DOI - PubMed
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. 10.1038/clpt.1981.154 - DOI - PubMed
    1. Carta M, Murru L, Botta P, Talani G, Sechi G, De Riu P, et al. The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system. Neuropharmacology. 2006;51:805–15. 10.1016/j.neuropharm.2006.05.023 - DOI - PubMed

Publication types